Cubist Systematic Strategies’s Gritstone bio, Inc. Common Stock GRTS Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2024
Q3
Sell
-20,739
Closed -$12.8K 3624
2024
Q2
$12.8K Buy
20,739
+20,317
+4,814% +$17.2K ﹤0.01% 2785
2024
Q1
$1.08K Buy
422
+416
+6,933% +$1.02K ﹤0.01% 3597
2023
Q4
$12 Hold
6
﹤0.01% 3508
2023
Q3
$10 Hold
6
﹤0.01% 3254
2023
Q2
$12 Sell
6
-17,658
-100% -$41.3K ﹤0.01% 3400
2023
Q1
$49.1K Sell
17,664
-5,300
-23% -$15.1K ﹤0.01% 3563
2022
Q4
$79.2K Sell
22,964
-179,073
-89% -$511K ﹤0.01% 3839
2022
Q3
$519K Sell
202,037
-67,310
-25% -$214K ﹤0.01% 3137
2022
Q2
$652K Buy
269,347
+96,169
+56% +$253K ﹤0.01% 2844
2022
Q1
$713K Buy
173,178
+130,222
+303% +$690K 0.01% 2290
2021
Q4
$552K Sell
42,956
-22,093
-34% -$245K 0.01% 2371
2021
Q3
$703K Buy
65,049
+29,525
+83% +$269K 0.01% 1793
2021
Q2
$324K Buy
35,524
+572
+2% +$5.29K ﹤0.01% 2280
2021
Q1
$330K Buy
+34,952
New +$481K ﹤0.01% 2199
2020
Q3
Sell
-11,780
Closed -$78K 2678
2020
Q2
$78K Buy
+11,780
New +$79.3K ﹤0.01% 2239

Other funds holding GRTS

Cubist Systematic Strategies's GRTS Position: Q3 2024 in Review

Cubist Systematic Strategies sold out of Gritstone bio, Inc. Common Stock (GRTS) in Q3 2024, closing a stake of 20,739 shares — an estimated $12.8K sold.

Cubist Systematic Strategies first reported a position in GRTS in Q2 2020 and held it in 15 quarters. The position peaked at $713K in Q1 2022. 56 funds tracked by Wall St. Rank hold GRTS as of Q3 2024.

  • Cubist Systematic Strategies reported no remaining Gritstone bio, Inc. Common Stock position as of Q3 2024 after selling out during the quarter.
  • Cubist Systematic Strategies sold 20,739 Gritstone bio, Inc. Common Stock shares in Q3 2024, an estimated $12.8K.
  • Cubist Systematic Strategies first reported a position in Gritstone bio, Inc. Common Stock in Q2 2020 and held it in 15 quarters.
  • Cubist Systematic Strategies's Gritstone bio, Inc. Common Stock position peaked at $713K in Q1 2022.
  • 56 funds tracked by Wall St. Rank held Gritstone bio, Inc. Common Stock as of Q3 2024.

Based on Cubist Systematic Strategies's 13F filing for Q3 2024, filed 14 Nov 2024.